Assertio Therapeutics Inc
ASRT
$23.50+0.00%
Delayed · as of Sep 18, 2026, 10:15 AM ET
Mkt cap
$151.47M
EV/Sales
1.52
P/E ratio
N/A
FY2025 Revenue
$118.71M
EPS (FY2025)
$-4.74
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-25.59%
Beta
0.53
Div yield
N/A
Sector
Healthcare
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ASRT revenue for 2025-12-31 was $118.7M. Net income was -$30.4M. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. ASRT currently screens at market cap $151.5M.
Use this ASRT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ASRT income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Assertio Therapeutics Inc (ASRT) revenue for Dec 31, 2025 was $118.7M. Net income was -$30.4M. Statements: https://lician.com/financials/asrt
Assertio Therapeutics Inc (ASRT) market capitalization is $151.5M on the latest cached snapshot.
Assertio Therapeutics Inc (ASRT) cached previous close $23.50; day range $23.48 – $23.50; volume 270,191. Session quote: https://lician.com/quote/asrt
Assertio Therapeutics Inc (ASRT) latest cached earnings event is "ASRT earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ASRT filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/asrt